| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Yogesh Mannalal Agrawal M.B.A CEO | MSE Exchange | Y0R6E1145 CUSIP |
| India Country | 8,073 Employees | 5 Aug 2026 Last Dividend | 20 Mar 2015 Last Split | - IPO Date |
Ajanta Pharma Limited is a revered entity in the specialty pharmaceutical sector, known for its integrated approach to developing, manufacturing, and marketing pharmaceutical finished dosages. With a history that dates back to 1973, the company has established a significant footprint. Headquartered in Mumbai, India, Ajanta Pharma extends its services across diverse global markets, including Africa, other parts of Asia, the United States, and beyond. Catering to a variety of therapeutic segments like cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas, the company stands out for its commitment to addressing a broad spectrum of healthcare needs.
List of key offerings by Ajanta Pharma Limited:
Ajanta Pharma provides a comprehensive range of formulations designed to treat cardiovascular diseases, supporting patients with advanced therapeutics for heart health.
The company offers a variety of medicines aimed at managing diabetes, demonstrating its focus on chronic conditions that require ongoing care and sophisticated treatment regimens.
Ajanta Pharma’s ophthalmology division develops products for eye care, addressing conditions that range from routine problems to complex diseases requiring specialized treatment.
With a focus on skin health, the company’s dermatology products include treatments for a wide range of skin conditions, ensuring solutions for both common and rare dermatological challenges.
Catering to the pain management segment, Ajanta Pharma provides medications designed to alleviate various types of pain, offering relief and improving the quality of life for patients dealing with chronic or acute pain.
The company’s respiratory range includes treatments for disorders of the respiratory system, supporting individuals suffering from conditions that impact breathing and lung function.
Ajanta Pharma’s portfolio extends to a wide array of dosage forms, including tablets, capsules, and injectables, accommodating different therapeutic needs and preferences.
Further diversifying its product lineup, the company offers inhalers for respiratory issues, along with topical ointments, creams for dermatological use, and liquid formulations, ensuring comprehensive healthcare solutions.